The use of mexiprim in patients with chronic brain ischemia

Abstract

The observation of 40 patients with discirculatory encephalopathy Ist and IIed stage arising from Hypertensive disease and atherosclerosis. The Ist group - main, patients who received standard therapy in combination with mexiprim. The IIed group - control, patients who received only standard therapy. Evaluated dynamics of clinical manifestation, cognitive function and level of anxiety in the investigated groups after 14 and 28 days. Noted the high efficiency of mexiprim in treatment of clinical manifestation chronic brain ischemia, in comparison with standart therapy.

Keywords

• хроническая ишемия мозга
• когнитивные функции
• мексиприм
• chronic brain ischemia
• cognitive function
• mexiprim